Compare MCHX & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCHX | LNSR |
|---|---|---|
| Founded | 2003 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.3M | 71.7M |
| IPO Year | 2003 | 2005 |
| Metric | MCHX | LNSR |
|---|---|---|
| Price | $1.44 | $5.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 25.8K | ★ 65.3K |
| Earning Date | 11-10-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.56 |
| Revenue | ★ $90,291,000.00 | $58,435,000.00 |
| Revenue This Year | $16.21 | $4.22 |
| Revenue Next Year | $29.69 | $19.43 |
| P/E Ratio | ★ N/A | $8.88 |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $1.15 | $4.30 |
| 52 Week High | $2.00 | $12.94 |
| Indicator | MCHX | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 41.61 |
| Support Level | $1.25 | $5.17 |
| Resistance Level | $1.52 | $6.29 |
| Average True Range (ATR) | 0.13 | 0.36 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 43.33 | 56.00 |
Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.